496 related articles for article (PubMed ID: 26070903)
21. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.
Zhang HT; Zhang P; Gao Y; Li CL; Wang HJ; Chen LC; Feng Y; Li RY; Li YL; Jiang CL
Mol Med Rep; 2017 Jan; 15(1):57-64. PubMed ID: 27909732
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice.
Zuo X; Lu J; Manaenko A; Qi X; Tang J; Mei Q; Xia Y; Hu Q
Exp Neurol; 2019 Jun; 316():12-19. PubMed ID: 30930097
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.
Cheng Z; Zhang M; Ling C; Zhu Y; Ren H; Hong C; Qin J; Liu T; Wang J
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897756
[TBL] [Abstract][Full Text] [Related]
24. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia.
Zhu J; Jiang Y; Wu L; Lu T; Xu G; Liu X
Neuroscience; 2012 Jan; 202():342-51. PubMed ID: 22173011
[TBL] [Abstract][Full Text] [Related]
25. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
26. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.
Chen F; Wang W; Ding H; Yang Q; Dong Q; Cui M
J Neuroinflammation; 2016 Aug; 13(1):204. PubMed ID: 27566245
[TBL] [Abstract][Full Text] [Related]
27. Ginsenoside Rd attenuates blood-brain barrier damage by suppressing proteasome-mediated signaling after transient forebrain ischemia.
Zhang X; Liu X; Hu G; Zhang G; Zhao G; Shi M
Neuroreport; 2020 Apr; 31(6):466-472. PubMed ID: 32168101
[TBL] [Abstract][Full Text] [Related]
28. Intracerebroventricular Delivery of Recombinant NAMPT Deters Inflammation and Protects Against Cerebral Ischemia.
Chen F; Weng Z; Xia Q; Cao C; Leak RK; Han L; Xiao J; Graham SH; Cao G
Transl Stroke Res; 2019 Dec; 10(6):719-728. PubMed ID: 30820847
[TBL] [Abstract][Full Text] [Related]
29. Cordycepin attenuates traumatic brain injury-induced impairments of blood-brain barrier integrity in rats.
Yuan J; Wang A; He Y; Si Z; Xu S; Zhang S; Wang K; Wang D; Liu Y
Brain Res Bull; 2016 Oct; 127():171-176. PubMed ID: 27646481
[TBL] [Abstract][Full Text] [Related]
30. Ginsenoside Rb1 improves brain, lung, and intestinal barrier damage in middle cerebral artery occlusion/reperfusion (MCAO/R) micevia the PPARγ signaling pathway.
Su LJ; Ren YC; Chen Z; Ma HF; Zheng F; Li F; Zhang YY; Gong SS; Kou JP
Chin J Nat Med; 2022 Aug; 20(8):561-571. PubMed ID: 36031228
[TBL] [Abstract][Full Text] [Related]
31. Protective Effect of 4-Methoxy Benzyl Alcohol on the Blood-Brain Barrier after Cerebral Ischemia Reperfusion Injury.
He F; Duan X; Dai R; Li Y; Lin Q
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1258-1265. PubMed ID: 28396190
[TBL] [Abstract][Full Text] [Related]
32. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
33. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
[TBL] [Abstract][Full Text] [Related]
34. Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway.
Cao G; Jiang N; Hu Y; Zhang Y; Wang G; Yin M; Ma X; Zhou K; Qi J; Yu B; Kou J
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589720
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of ginsenoside-Rg1 on cerebral ischemia/reperfusion injury in rats by downregulating protease-activated receptor-1 expression.
Xie CL; Li JH; Wang WW; Zheng GQ; Wang LX
Life Sci; 2015 Jan; 121():145-51. PubMed ID: 25498890
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
37. Partially purified components of Uncaria sinensis attenuate blood brain barrier disruption after ischemic brain injury in mice.
Seo HB; Kang BK; Kim JH; Choi YW; Hong JW; Choi BT; Shin HK
BMC Complement Altern Med; 2015 May; 15():157. PubMed ID: 26012470
[TBL] [Abstract][Full Text] [Related]
38. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
[TBL] [Abstract][Full Text] [Related]
39. Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke.
Liu B; Li Y; Han Y; Wang S; Yang H; Zhao Y; Li P; Wang Y
Phytomedicine; 2021 Sep; 90():153660. PubMed ID: 34344565
[TBL] [Abstract][Full Text] [Related]
40. [Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats].
Ni C; Zeng N; Xu F; Gou L; Liu J; Wang J; Xia H
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2562-6. PubMed ID: 22256767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]